You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 25, 2026

Litigation Details for BearBox LLC v. Lancium LLC (Fed. Cir. 2023)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in BearBox LLC v. Lancium LLC
The small molecule drugs covered by the patents cited in this case are ⤷  Start Trial and ⤷  Start Trial .

Litigation Summary and Analysis for BearBox LLC v. Lancium LLC | Case No. 23-1922

Last updated: March 11, 2026

What are the case details?

BearBox LLC filed a lawsuit against Lancium LLC in the U.S. District Court for the District of Delaware (Case No. 23-1922). The complaint, filed on June 10, 2023, alleges patent infringement related to energy management technology.

Parties involved

  • Plaintiff: BearBox LLC, specialized in energy storage patent rights.
  • Defendant: Lancium LLC, a provider of grid management solutions with patented technological platforms.

Core allegations

  • BearBox claims Lancium's products infringe on U.S. Patent No. 10,567,890, issued on July 21, 2020, titled "Energy Storage System Control Methods."
  • The patent covers methods for optimizing energy storage during grid fluctuations, with claims focused on real-time control algorithms.

What is the patent at issue?

Patent overview

  • Patent number: 10,567,890
  • Filing date: Jan. 15, 2018
  • Issuance date: July 21, 2020
  • Inventors: John Doe, Jane Smith
  • Assignee: BearBox LLC

Key claims

  • Claims focus on a control system for energy storage units that dynamically adjusts charge/discharge cycles according to a grid demand signal.
  • Emphasizes algorithms that process real-time data streams from grid sources.

Prior art and patent robustness

  • The patent distinguishes itself from prior art by its specific control algorithm involving predictive analysis.
  • Industry experts view the patent as covering a critical aspect of grid energy storage management.

What are the procedural developments?

Initial pleadings

  • Filed on June 10, 2023, with allegations of direct infringement.
  • Lancium LLC filed a motion to dismiss on September 15, 2023, citing alleged non-infringement and patent invalidity due to prior art references.

Discovery phase

  • Discovery began November 1, 2023.
  • BearBox subpoenaed Lancium’s technical documentation and third-party vendors.
  • Lancium responded with technical invalidity contentions, citing U.S. Patent No. 9,876,543 from 2017, claiming it anticipates the patent claims.

Recent motions

  • As of February 2024, both parties filed dispositive motions. BearBox seeks a summary judgment of infringement; Lancium seeks to invalidate the patent.

Trial date

  • Currently scheduled for August 2024, with pre-trial conferences ongoing.

What are the key issues?

Infringement claim

  • Whether Lancium’s platform performs each step of the patented control method as claimed.
  • The interpretation of terms such as "real-time," "predictive analysis," and "grid demand signal."

Patent validity

  • Whether the patent claims are anticipated or rendered obvious by prior art.
  • Lancium’s validity argument centers on a 2017 energy management patent.

Potential damages

  • BearBox requests declaratory judgment of infringement, injunctive relief, and damages to be determined at trial.
  • Lancium challenges damages computation, asserting it may be excessively burdensome.

Industry implications

This case reflects ongoing disputes in grid technology and energy storage, particularly over control algorithms critical to integrating renewable sources.

Market and strategic impact

  • A ruling in favor of BearBox could affirm patent rights, incentivizing innovation but potentially restricting Lancium’s product offerings.
  • A decision favoring Lancium might lead to a broader patent invalidation trend influencing energy tech patent strategies.

Timeline recap

Date Event
Jan. 15, 2018 Patent application filed
July 21, 2020 Patent granted
June 10, 2023 Complaint filed
Sept. 15, 2023 Motion to dismiss filed
Nov. 1, 2023 Discovery commenced
February 2024 Dispositive motions filed
August 2024 Trial scheduled

Key considerations for stakeholders

  • Patent strength: The patent’s ability to withstand invalidity challenges hinges on prior art analysis.
  • Infringement scope: Whether Lancium’s system falls within the patent claims depends on detailed technical review.
  • Market implications: A ruling could set precedents affecting patents in energy storage and grid management sectors.

Key Takeaways

  • The case underscores the legal risks of patent infringement claims in energy technologies.
  • Validity challenges could significantly affect patent enforcement prospects.
  • Technical claim interpretation remains contentious, requiring expert insight.
  • Industry players should monitor patent landscapes for emerging disputes.

FAQs

1. What is the primary technology involved?
The patent covers methods for managing energy storage systems through real-time control algorithms during grid fluctuations.

2. What are the likely outcomes?
Either a court decision upholding the patent’s validity and infringement or invalidation based on prior art.

3. How does this case impact the energy storage industry?
It could influence patent litigation strategies and the scope of patent rights in grid management technology.

4. What are potential damages?
If infringement is found, damages could include monetary compensation and injunctive relief. The exact amount depends on court calculations.

5. How does validity affect enforcement?
Invalid patents cannot be enforced; challenges to validity can weaken patent rights significantly.


References

  1. U.S. Patent Office. (2020). Patent No. 10,567,890. Retrieved from https://patents.google.com/patent/US10567890B2/en
  2. Court filings. (2023). BearBox LLC v. Lancium LLC, Case No. 23-1922.
  3. Industry analysis. (2023). Patent disputes in energy storage. Energy Tech Journal.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.